Vanguard Portfolio Management
CLMT icon

Vanguard Portfolio Management’s Calumet Specialty Products CLMT Stock Holding History

Vanguard Portfolio Management’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.9M Buy
1,025,321
+95,069
+10% +$3.2M ﹤0.01% 1801
2026
Q1 		$33.4M Buy
+930,252
New +$24.1M ﹤0.01% 1769

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management's CLMT Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Calumet Specialty Products (CLMT) stake by 10% in Q2 2026, buying an estimated $3.2M and bringing the position to 1,025,321 shares worth $36.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

Vanguard Portfolio Management first reported a position in CLMT in Q1 2026 and has held it in 2 quarters since. 187 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Vanguard Portfolio Management held 1,025,321 shares of Calumet Specialty Products worth $36.9M as of Q2 2026.
  • Vanguard Portfolio Management bought 95,069 Calumet Specialty Products shares in Q2 2026, an estimated $3.2M.
  • Calumet Specialty Products made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1801 holding.
  • Vanguard Portfolio Management first reported a position in Calumet Specialty Products in Q1 2026 and has held it in 2 quarters since.
  • 187 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.